United States

Policy

FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates

The regulator placed the clinical hold on the Chinese biotech’s trio of CAR-T cell therapy candidates after an inspection of its Durham, North Carolina manufacturing facility.

December 15, 2023

2 min read

Tyler Patchen

Job Trends

New Lilly Manufacturing Plant to Bring 600 Jobs to North Carolina

Eli Lilly and Company announced plans to build a new manufacturing plant in Concord, North Carolina.

January 31, 2022

2 min read

Mark Terry

PRESS RELEASES

Press Releases

JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

January 15, 2026

9 min read

Press Releases

Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral ‘XAFTY’ Following 2026 Biotech Showcase Consensus

January 15, 2026

3 min read

Press Releases

Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer

January 15, 2026

3 min read

Press Releases

Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7-activating rdHSV-CA8* Therapy in the Treatment of Erythromelalgia

January 15, 2026

7 min read

Press Releases

Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting

January 15, 2026

7 min read

Press Releases

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

January 15, 2026

9 min read

Press Releases

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

January 15, 2026

9 min read

Press Releases

TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide

January 15, 2026

34 min read

Press Releases

BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

January 15, 2026

7 min read

Press Releases

Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology

January 15, 2026

8 min read

Press Releases

VizMark Secures FDA 510k Clearance for VM1 Visual Tumor Marker, Advancing Precision in Breast Cancer Imaging

January 15, 2026

1 min read

Press Releases

DANA FOUNDATION APPOINTS KELSEY MARTIN TO BOARD OF DIRECTORS

January 15, 2026

3 min read

Press Releases

FDA Approves Updated Label for Miach Orthopaedics’ BEAR® Implant to Include Significantly Lower Risk of Osteoarthritis

January 15, 2026

5 min read

Press Releases

Howard R. Soule, Ph.D., to Retire as Chief Science Officer of the Prostate Cancer Foundation

January 15, 2026

5 min read

Press Releases

Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.

January 15, 2026

3 min read

Press Releases

AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab

January 15, 2026

5 min read

Press Releases

Department of War Technology Veteran Katie Arrington Joins IonQ as Chief Information Officer (CIO)

January 15, 2026

4 min read

Press Releases

Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle Invasive Bladder Cancer with Carcinoma In-Situ

January 15, 2026

8 min read

Press Releases

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

January 15, 2026

4 min read

Press Releases

TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer

January 15, 2026

3 min read